de Jong EMGJ - Search Results

1

Adalimumab combined with methotrexate versus adalimumab monotherapy in psoriasis: Three-year follow-up data of a single-blind randomized controlled trial.

van Huizen AM, van der Kraaij GE, Busard CI, Ouwerkerk W, van den Reek JMPA, Menting SP, Prens EP, Rispens T, de Vries A, de Jong EMGJ, Lambert J, van Doorn MBA, Spuls PI. van Huizen AM, et al. Among authors: de jong emgj, de vries a. J Eur Acad Dermatol Venereol. 2023 Sep;37(9):1815-1824. doi: 10.1111/jdv.19089. Epub 2023 Apr 17. J Eur Acad Dermatol Venereol. 2023. PMID: 37014287 Clinical Trial.

2

A phase II multicenter clinical trial of systemic bexarotene in psoriasis.

Smit JV, Franssen ME, de Jong EM, Lambert J, Roseeuw DI, De Weert J, Yocum RC, Stevens VJ, van De Kerkhof PC. Smit JV, et al. J Am Acad Dermatol. 2004 Aug;51(2):249-56. doi: 10.1016/j.jaad.2002.08.001. J Am Acad Dermatol. 2004. PMID: 15280844 Clinical Trial.

3

Evaluation of the reimbursement criteria for biological therapies for psoriasis in the Netherlands.

Wakkee M, Thio HB, Spuls PI, de Jong EM, Nijsten T. Wakkee M, et al. Br J Dermatol. 2008 May;158(5):1159-61. doi: 10.1111/j.1365-2133.2008.08512.x. Epub 2008 Mar 20. Br J Dermatol. 2008. PMID: 18363749 No abstract available.

4

Etanercept combined with methotrexate for high-need psoriasis.

Driessen RJ, van de Kerkhof PC, de Jong EM. Driessen RJ, et al. Br J Dermatol. 2008 Aug;159(2):460-3. doi: 10.1111/j.1365-2133.2008.08669.x. Epub 2008 Jun 28. Br J Dermatol. 2008. PMID: 18547310

5

Knowledge, attitudes and use of the guidelines for the treatment of moderate to severe plaque psoriasis among Dutch dermatologists.

Wakkee M, Lugtenberg M, Spuls PI, de Jong EM, Thio HB, Westert GP, Nijsten T. Wakkee M, et al. Br J Dermatol. 2008 Aug;159(2):426-32. doi: 10.1111/j.1365-2133.2008.08692.x. Epub 2008 Jul 4. Br J Dermatol. 2008. PMID: 18616791

6

Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis.

Lecluse LL, Driessen RJ, Spuls PI, de Jong EM, Stapel SO, van Doorn MB, Bos JD, Wolbink GJ. Lecluse LL, et al. Arch Dermatol. 2010 Feb;146(2):127-32. doi: 10.1001/archdermatol.2009.347. Arch Dermatol. 2010. PMID: 20157022

7

Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept.

Van Lümig PP, Lecluse LL, Driessen RJ, Spuls PI, Boezeman JB, van de Kerkhof PC, De Jong EM. Van Lümig PP, et al. Br J Dermatol. 2010 Oct;163(4):838-46. doi: 10.1111/j.1365-2133.2010.09950.x. Epub 2010 Sep 2. Br J Dermatol. 2010. PMID: 20649798 Clinical Trial.

8

An intrapatient comparison of quality of life in psoriasis in childhood and adulthood.

de Jager ME, de Jong EM, van de Kerkhof PC, Evers AW, Seyger MM. de Jager ME, et al. J Eur Acad Dermatol Venereol. 2011 Jul;25(7):828-31. doi: 10.1111/j.1468-3083.2010.03872.x. Epub 2010 Oct 6. J Eur Acad Dermatol Venereol. 2011. PMID: 21039918

9

Safety of treatment with biologics for psoriasis in daily practice: 5-year data.

van Lümig PP, Driessen RJ, Berends MA, Boezeman JB, van de Kerkhof PC, de Jong EM. van Lümig PP, et al. J Eur Acad Dermatol Venereol. 2012 Mar;26(3):283-91. doi: 10.1111/j.1468-3083.2011.04044.x. Epub 2011 Mar 24. J Eur Acad Dermatol Venereol. 2012. PMID: 21435026

10

Adalimumab therapy for psoriasis in real-world practice: efficacy, safety and results in biologic-naïve vs. non-naïve patients.

van Lümig PP, van de Kerkhof PC, Boezeman JB, Driessen RJ, de Jong EM. van Lümig PP, et al. J Eur Acad Dermatol Venereol. 2013 May;27(5):593-600. doi: 10.1111/j.1468-3083.2012.04496.x. Epub 2012 Mar 15. J Eur Acad Dermatol Venereol. 2013. PMID: 22416818

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

286 results

Search Page